Yield10 Bioscience Inc (NASDAQ:YTEN) price closed lower on Tuesday, March 26, dropping -4.94% below its previous close.
A look at the daily price movement shows that the last close reads $0.36. The company’s 5Y monthly beta was ticking 1.52. Taking into account the 52-week price action we note that the stock hit a 52-week high of $3.29 and 52-week low of $0.18. The stock added 42.58% on its value in the past month.
Yield10 Bioscience Inc, which has a market valuation of $4.10 million, is expected to release its quarterly earnings report May 08, 2024 – May 13, 2024. Analysts tracking YTEN have forecast the quarterly EPS to shrink by -0.3 per share this quarter, while the same analysts predict the annual EPS to hit -$1.99 for the year 2024 and up to -$1.19 for 2024. In this case, analysts estimate an annual EPS growth of 27.90% for the year and 40.20% for the next year.
Staying with the analyst view, there is a consensus estimate of $80k for the company’s annual revenue in 2023. Per this projection, the revenue is forecast to grow -82.20% below that which the company brought in 2023.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give YTEN a short term outlook of 50% Buy on average. Looking at the stock’s medium term indicators we note that it is averaging as a Hold, while an average of long term indicators are currently assigning the stock as Hold.
The overview shows that YTEN’s price is at present 25.35% off the SMA20 and 31.78% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 58.87, with weekly volatility standing at 30.52%. The indicator jumps to 16.24% when calculated based on the past 30 days. Yield10 Bioscience Inc (NASDAQ:YTEN)’s beta value is holding at 1.56, while the average true range (ATR) indicator is currently reading 0.06.
An analysis of the Yield10 Bioscience Inc (NASDAQ:YTEN) stock in terms of its daily trading volume indicates that the 3-month average is 4.43 million. However, this figure increases on the past 10-day timeline to an average of 12.67 million.
Current records show that the company has 11.98M in outstanding shares. The insiders’ percentage holdings are 18.81% of outstanding shares while the percentage share held by institutions stands at 5.07%. The stats also highlight that short interest as of Feb 29, 2024, stood at 0.29 million shares, which puts the short ratio at the time at 0.05. From this we can glean that short interest is 2.42% of company’s current outstanding shares. Notably, we see that shares short in February rose slightly given the previous month’s figure stood at 50150.0. But the 43.00% upside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
